Skip to main content

Merck COVID drug linked to new virus mutations, study says

By Bloomberg.com  
   February 02, 2023

Merck & Co.'s COVID-19 pill is giving rise to new mutations of the virus in some patients, according to a study that underscores the risk of trying to intentionally alter the pathogen's genetic code.

Full story


Get the latest on healthcare leadership in your inbox.